Methotrexate and epirubicin conjugates as potential antitumor drugs

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue

Abstract

Introduction: The use of hybrid molecules has become one of the most significant approaches in new cytotoxic drug design. This study describes synthesis and characterization of conjugates consisting of two well-known and characterized chemotherapeutic agents: methotrexate (MTX) and epirubicin (EPR). The synthesized conjugates combine two significant anticancer strategies: combinatory therapy and targeted therapy. These two drugs were chosen because they have different mechanisms of action, which can increase the anticancer effect of the obtained conjugates. MTX, which is a folic acid analog, has high cytotoxic properties and can serve as a targeting moiety that can reach folate receptors (FRs) overexpresing tumor cells. Combination of nonselective drugs such as EPR with MTX can increase the selectivity of the obtained conjugates, while maintaining the high cytotoxic properties.Materials and methods: Conjugates were purified by RP-HPLC and the structure was investigated by MS and MS/MS methods. The effect of the conjugates on proliferation of LoVo, LoVo/Dx, MCF-7 and MV-4-11 human cancer cell lines was determined by SRB or MTT assay.Results: The conjugation reaction results in the formation of monosubstituted (α, γ) and disubstituted MTX derivatives. In vitro proliferation data demonstrate that the conjugates synthesized in our study show lower cytotoxic properties than both chemotherapeutics used alone.Discussion: Epirubicin cytotoxicity was not observed in obtained conjugates. Effective drugs release after internalization needs further investigation.

Authors and Affiliations

Szymon Wojciech Kmiecik, Mateusz Adam Krzyścik, Beata Filip-Psurska, Joanna Wietrzyk, Janusz Boratyński, Tomasz Marek Goszczyński

Keywords

Related Articles

Well-known and new variants of pathogenic Escherichia coli as a consequence of the plastic genome

E. coli is a diverse bacterial species encompassing commensal as well as intestinal and extraintestinal pathogenic strains. The ability to adapt to so many different niches in the host organism is determined by the extre...

Nerkowy katabolizm albuminy – aktualne poglądy i kontrowersje

Albumina jest głównym białkiem osocza krwi, chłonki, płynu mózgowo-rdzeniowego oraz śródmiąższowego. Białko to pełni w organizmie wiele ważnych funkcji, m.in. utrzymuje prawidłowe ciśnienie koloido-osmotyczne, transportu...

Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseases

Glutamate is the basic excitatory neurotransmitter acting via N-methyl-D-aspartate receptors (NMDARs). It co-regulates many important physiological functions, including learning, memory, and behaviour. An excess of glu...

Lysozyme – occurrence in nature, biological properties and possible applications

Lysozyme (LZ, muramidase, N-acetylmuramylhydrolase) is a protein occuring in animals, plants, bacteria and viruses. It can be found e.g. in granules of neutrophils, macrophages and in serum, saliva, milk, honey and hen e...

The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis

Extracellular matrix metalloproteinases (MMPs) are a family of endopeptydases which recquire a zinc ion at their active site, for proteolityc activity. There are six members of the MMP family: matrilysins, collagenases,...

Download PDF file
  • EP ID EP220408
  • DOI 10.5604/01.3001.0010.3842
  • Views 114
  • Downloads 0

How To Cite

Szymon Wojciech Kmiecik, Mateusz Adam Krzyścik, Beata Filip-Psurska, Joanna Wietrzyk, Janusz Boratyński, Tomasz Marek Goszczyński (2017). Methotrexate and epirubicin conjugates as potential antitumor drugs. Advances in Hygiene and Experimental Medicine, 71(), 618-623. https://europub.co.uk/articles/-A-220408